Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Filings indexed 1,491 across all filing types
Latest filing 2019-12-03 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions within the board and its committees. It includes details about executive, non-executive, and independent non-executive directors, as well as their committee memberships. There is no financial data, no mention of a report or meeting results, and no indication of a report publication or regulatory filing. The content is focused on board and management information, specifically the composition and roles of the board of directors. Therefore, the document fits best under the category 'Board/Management Information' (MANG). The document length is short and purely informational about board members, which aligns with MANG rather than other categories.
2019-12-03 English
(1) RESIGNATION OF EXECUTIVE DIRECTOR AND (2) APPOINTMENT OF AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of 3SBio Inc. regarding the resignation of an executive director and the appointment of an authorised representative. It contains no financial data, no report or presentation, and focuses solely on changes in the company's board and management positions. The document length is short (2718 characters), and it is clearly a management change announcement. Therefore, it fits the category of Board/Management Information (MANG).
2019-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related capital changes for the month ended 30/11/2019. The content focuses exclusively on share capital changes and related securities movements, with no financial performance data, earnings, or management commentary. This type of document is a regulatory filing reporting capital changes and share movements to the exchange, consistent with a Share Issue/Capital Change announcement. It is not a full financial report, earnings release, or management report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (15,000 characters) and detailed data confirm it is the report itself, not just an announcement of a report publication.
2019-12-02 English
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019' and contains detailed unaudited condensed consolidated financial statements including profit or loss, comprehensive income, financial position, and notes on accounting policies. It explicitly states it is prepared in accordance with HKAS 34 Interim Financial Reporting and includes comparative figures for the prior period. The document length is substantial (15,000 characters) and contains actual financial data and analysis for a period shorter than a full fiscal year (six months). This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report. Therefore, the correct classification is IR with high confidence. H1 2020
2019-11-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Hongkong Chinese Limited regarding the date of a Board meeting to approve the unaudited consolidated interim results for the six months ended 30 September 2019 and to consider the payment of an interim dividend. The document is short (1540 characters) and does not contain any actual financial data or detailed financial statements. It is a notice about the timing of a board meeting and the agenda, not the interim report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general announcement rather than an Interim Report (IR) or Earnings Release (ER).
2019-11-18 English
VOLUNTARY ANNOUNCEMENT GRANT OF LICENSE BY VERSEAU FOR ITS PSGL-1-TARGETED ANTIBODY VTX-0811, A MACROPHAGE CHECKPOINT MODULATOR IN IMMUNO-ONCOLOGY
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding a licensing agreement and research collaboration with Verseau Therapeutics for a novel antibody in immuno-oncology. It is a press release style announcement about a business development and partnership, not a financial report, regulatory filing, or management report. There are no financial statements, earnings data, or governance changes. The document is about a licensing deal and collaboration update, which fits best under Capital/Financing Update (CAP) as it relates to licensing and partnership agreements impacting company capital and business development. The document length is 9424 characters, sufficient for a detailed announcement but it is not a report or transcript. Therefore, the classification is CAP with high confidence.
2019-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.